COMBINE Group retweeted
È stata rinviata a giovedì 11 luglio 2024, a causa dell'improvvisa scomparsa del prof. Antonino Recca, già rettore dell'Università di Catania, l'iniziativa Piaceri Day 2024 - Focus sul Piano di incentivi per la ricerca Unict, inizialmente prevista per domani, mercoledì 10 luglio.
COMBINE Group retweeted
🎓📢SCHEDA DI DOTTORATO “INFORMATICA”: unict.it/sites/default/files…
Per maggiori dettagli e per inviare la tua candidatura, visita il sito web: unict.it/sites/default/files…
Non perdere l'occasione di far parte di una comunità di ricercatori dinamica e di eccellenza. Ti aspettiamo!
COMBINE Group retweeted
"Regulatory barriers to the adoption of #insilicotrials" is an extensive report that summarises and analyses the #InSilicoWorld consortium's work concerning the #regulatory #barriers and draws some recommendations for EU #policymakers.
Full document ⬇️
bit.ly/3PW0PtC
COMBINE Group retweeted
💊 UISS (Universal Immune System Simulator) is able to model the human immune system and its responses to viruses, bacteria, and more. Among those, UISS-TB can model the response to #Tuberculosis and TB treatments
👉vph-institute.org/news/a-new…
#wordlTBday #fightTB #endTB
COMBINE Group retweeted
2nd day in Catania for the #InSilicoWorld General Assembly! So proud to see all our partners did so well in these years, many great results have been achieved!
We are shaping the future of #healthcare and we cannot wait to have our final showcase event at #VPH2024 in Stuttgart!
COMBINE Group retweeted
Live for the In Silico World #workshop!
An international group of experts from academia, industry, and the regulatory/standardisation world is discussing the #regulatory challenges of #insilicotrials.
All this in an amazing historic venue in Catania🇮🇹 @unict_it
COMBINE Group retweeted
In this #workshop, an international group of experts from academia, industry, & the regulatory/standardisation world will discuss the challenges of #regulatory barriers in conducting #insilicotrials.
Time is ticking!⌚️
14th March 2024 - 14:00 CET
(Remote)
FREE Registration👇
🎉 Exciting News! The In Silico World #Workshop on "The Regulatory Barriers To In Silico Trials" will also be available ONLINE! Don't miss it!
Date: 14th March 2024
Time: 14:00 - 18:30 CET
Place: Live in Catania / Online on MS Teams
FREE registration 👇
bit.ly/3P2uWPl
COMBINE Group retweeted
🎉 Exciting News! The In Silico World #Workshop on "The Regulatory Barriers To In Silico Trials" will also be available ONLINE! Don't miss it!
Date: 14th March 2024
Time: 14:00 - 18:30 CET
Place: Live in Catania / Online on MS Teams
FREE registration 👇
bit.ly/3P2uWPl
COMBINE Group retweeted
Pionieri della #Medicina In Silico per un futuro più salutare
Lo spinoff Mimesis, nato nel 2020 all'interno di @unict_it , da sempre al servizio dell’industria #biomedica e delle aziende #farmaceutiche
Su #UnictMagazine di #Unict
unictmagazine.unict.it/pioni…
COMBINE Group retweeted
#goodnews Mimesis, il riconoscimento della European Medicines Agency per la ricerca biomedica allo spin-off di @unict_it
Su #UnictMagazine di #Unict
unictmagazine.unict.it/mimes…
COMBINE Group retweeted
🎉 Double the Thrills, Double the Chills! 🎉 Exciting news alert! 🚀 We're featured not once, but TWICE in Unict magazine today! 📰✨ Dive into the world of MImesis and discover groundbreaking updates from the (EMA). Don't miss out! unictmagazine.unict.it/
COMBINE Group retweeted
As the #InSilicoTrials field expands, some large universities might have opportunities to develop a specialised curriculum.
Here's a proposal for curricula - drafted by #InSilicoWorld - to train & retrain technical & non-technical stakeholders on IST.
👇
bit.ly/3GOUPxM
COMBINE Group retweeted
A quick overview by Prof @MarcoViceconti of the barriers that are slowing down the uptake of modeling and simulation technologies used for the development and regulatory assessment of medicines and medical devices. #insilico
Watch the full interview on YT youtu.be/kh87Z7Ckrag
COMBINE Group retweeted
Yesterday we were invited inside the Faculty of Mathematics and Informatics at Unict to present Mimesis to young students and graduates.Being able to make young people aware of our work and the developments of the in Silico technology is always a success for us. Thank you
COMBINE Group retweeted
🙌Happy to share that the paper "#insilico #clinicaltrials for Relapsing-remitting Multiple Sclerosis with MS TreatSim” was published in BMC Medical Informatics and Decision Making
Authors: Fianne Sips @ProfPappalardo Giulia Russo @unict12 Roberta Bursi
bmcmedinformdecismak.biomedc…
COMBINE Group retweeted
Replying to @WHO
@WHO published the 2022 Global #Tuberculosis Report that provides up-to-date assessment of the #TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels ➡️who.int/teams/global-tubercu…
COMBINE Group retweeted
Don't forget to register for our free webinar taking place on 24 Nov, 11-12.15 (UK time) exploring challenges to #tuberculosis drug development and access
This event will be hosted by our partner member @NICEComms
Register now: https://xitter.gq/t.co/40lmAo7izU
@AMR_Combine @TBAlliance
COMBINE Group retweeted
We'll be there! On 29 Sept at 3pm CEST Partners from @DsfsUnict @COMBINE_Group will join the Coffee Corner for researchers in the #TB community to present UISS simulator, used to predict the response of the human immune system to the exposure of #tuberculosis 💻 Registration 👇
Calling all Early Career Researchers❗️@newtbvaccines is hosting a Coffee Corner virtual gathering for ECRs in the TB R&D community ☕️
Join us to chat & discuss the daily grind 💬
🗓 29 September
⏰ 9:00am EDT | 3:00pm CEST & SAST | 6:30pm IST
Register 🔗 tinyurl.com/2p87m66x
COMBINE Group retweeted
Mancano 6 giorni alla nuova edizione #SharperNightCatania. Venerdì 𝟯𝟬 𝘀𝗲𝘁𝘁𝗲𝗺𝗯𝗿𝗲 si festeggia il valore della #ricerca e #Catania partecipa con un programma ricco di eventi
Vai al programma 👉https://xitter.gq/t.co/kjTNCGGSe6
youtu.be/RVr25xp1wNs via @YouTube






























